Filing Details
- Accession Number:
- 0001140361-13-040757
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-05 19:55:05
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2013-11-05
- Accepted Time:
- 2013-11-05 19:55:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Svp, Chief Commercial Of | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-10-31 | 99 | $27.91 | 14,979 | No | 5 | A | Direct | |
Common Stock | Disposition | 2013-11-01 | 99 | $63.16 | 14,880 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2013 to October 31, 2013.
- Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.